EOLA2-DT

Summary

EOLA2-DT (EOLA2 divergent transcript, HGNC:48579) is a long non-coding RNA gene on chromosome Xq28.

At a glance

• Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

Field	Value
HGNC ID	HGNC:48579
Approved symbol	EOLA2-DT
Name	EOLA2 divergent transcript
Location	Xq28
Locus type	RNA, long non-coding
Status	Approved
Ensembl gene	ENSG00000235703
Ensembl biotype	lncRNA
Entrez	100272228
RNAcentral	URS000075C601 — lncRNA, 3285 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 31 — 31 lncRNA

ENST00000413076, ENST00000425602, ENST00000432696, ENST00000444489, ENST00000449111, ENST00000450989, ENST00000452864, ENST00000455777, ENST00000458274, ENST00000654890, ENST00000669126, ENST00000670799, ENST00000671125, ENST00000690321, ENST00000835572, ENST00000835573, ENST00000835574, ENST00000835575, ENST00000835576, ENST00000835577, ENST00000835578, ENST00000835579, ENST00000835580, ENST00000835581, ENST00000835582, ENST00000835583, ENST00000835584, ENST00000835585, ENST00000835586, ENST00000840895, ENST00000840896

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000413076 — 2 exons

Exon	Start	End
ENSE00001790957	150014876	150016500
ENSE00003873050	150016611	150016643

Expression profiles

Bgee: expression breadth ubiquitous, 243 present calls, max score 96.70.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.5878 / max 71.1988, expressed in 1100 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter ID	TPM avg	Samples expressed
197954	3.5572	1088
197956	0.0243	7
197955	0.0063	2

Top tissues by expression

273 total, by Bgee expression score (0-100, higher = more expressed):

Tissue	Anatomy ID	Expression score	Quality
right uterine tube	UBERON:0001302	96.70	gold quality
sural nerve	UBERON:0015488	93.25	gold quality
adenohypophysis	UBERON:0002196	93.18	gold quality
left ovary	UBERON:0002119	91.70	gold quality
right ovary	UBERON:0002118	91.43	gold quality
pituitary gland	UBERON:0000007	90.99	gold quality
right lobe of thyroid gland	UBERON:0001119	90.20	gold quality
body of uterus	UBERON:0009853	90.09	gold quality
left uterine tube	UBERON:0001303	89.34	gold quality
left lobe of thyroid gland	UBERON:0001120	89.32	gold quality
tibial nerve	UBERON:0001323	88.93	gold quality
thyroid gland	UBERON:0002046	88.80	gold quality
ectocervix	UBERON:0012249	88.67	gold quality
endocervix	UBERON:0000458	88.56	gold quality
popliteal artery	UBERON:0002250	88.02	gold quality
ascending aorta	UBERON:0001496	88.01	gold quality
tibial artery	UBERON:0007610	88.00	gold quality
aorta	UBERON:0000947	87.77	gold quality
thoracic aorta	UBERON:0001515	87.76	gold quality
descending thoracic aorta	UBERON:0002345	87.34	gold quality
muscle layer of sigmoid colon	UBERON:0035805	87.25	gold quality
right coronary artery	UBERON:0001625	87.05	gold quality
esophagogastric junction muscularis propria	UBERON:0035841	87.05	gold quality
apex of heart	UBERON:0002098	86.69	gold quality
left coronary artery	UBERON:0001626	86.52	gold quality
lower esophagus	UBERON:0013473	86.43	gold quality
lower esophagus muscularis layer	UBERON:0035833	86.43	gold quality
right hemisphere of cerebellum	UBERON:0014890	86.33	gold quality
minor salivary gland	UBERON:0001830	86.20	gold quality
ovary	UBERON:0000992	85.84	gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

Experiment	Marker?	Max mean expression
E-ANND-3	yes	4.23

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 1)

• LINC00894 inhibited neuron cellular apoptosis and regulated activating transcription factor 3 expression. (PMID:38857714)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.